Abstract: Metal chelators of Formula I and Formula II are disclosed: or a pharmaceutically acceptable salt thereof. Also disclosed are metal chelator-targeting moiety complexes, metal chelator-targeting moiety-metal conjugates, kits, and methods of their preparation and use in diagnosis and/or treatment of diseases and conditions, including, inter alia, cancer and thrombosis.
Type:
Application
Filed:
April 1, 2010
Publication date:
July 29, 2010
Applicant:
The Government of the United States of America, as represented by the Secretary, Dept. of Homeland a